Authors’ Reply to Yajing Du's Letter to the Editor on “Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC”

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e166-e168
JournalJournal of Thoracic Oncology
Volume15
Issue number10
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this